1. Home
  2. NIM vs VXRT Comparison

NIM vs VXRT Comparison

Compare NIM & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NIM
  • VXRT
  • Stock Information
  • Founded
  • NIM 1992
  • VXRT N/A
  • Country
  • NIM United States
  • VXRT United States
  • Employees
  • NIM N/A
  • VXRT N/A
  • Industry
  • NIM Trusts Except Educational Religious and Charitable
  • VXRT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NIM Finance
  • VXRT Health Care
  • Exchange
  • NIM Nasdaq
  • VXRT Nasdaq
  • Market Cap
  • NIM 111.9M
  • VXRT 119.0M
  • IPO Year
  • NIM N/A
  • VXRT N/A
  • Fundamental
  • Price
  • NIM $9.13
  • VXRT $0.42
  • Analyst Decision
  • NIM
  • VXRT Strong Buy
  • Analyst Count
  • NIM 0
  • VXRT 2
  • Target Price
  • NIM N/A
  • VXRT $3.00
  • AVG Volume (30 Days)
  • NIM 35.4K
  • VXRT 1.4M
  • Earning Date
  • NIM 01-01-0001
  • VXRT 05-13-2025
  • Dividend Yield
  • NIM 3.46%
  • VXRT N/A
  • EPS Growth
  • NIM N/A
  • VXRT N/A
  • EPS
  • NIM N/A
  • VXRT N/A
  • Revenue
  • NIM N/A
  • VXRT $28,700,000.00
  • Revenue This Year
  • NIM N/A
  • VXRT N/A
  • Revenue Next Year
  • NIM N/A
  • VXRT N/A
  • P/E Ratio
  • NIM N/A
  • VXRT N/A
  • Revenue Growth
  • NIM N/A
  • VXRT 288.94
  • 52 Week Low
  • NIM $8.28
  • VXRT $0.28
  • 52 Week High
  • NIM $9.74
  • VXRT $1.07
  • Technical
  • Relative Strength Index (RSI)
  • NIM 47.98
  • VXRT 52.21
  • Support Level
  • NIM $9.08
  • VXRT $0.37
  • Resistance Level
  • NIM $9.22
  • VXRT $0.38
  • Average True Range (ATR)
  • NIM 0.17
  • VXRT 0.04
  • MACD
  • NIM -0.01
  • VXRT 0.01
  • Stochastic Oscillator
  • NIM 31.48
  • VXRT 59.73

About NIM Nuveen Select Maturities Municipal Fund

Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital by investing in an investment-grade quality portfolio of municipal obligations with intermediate characteristics.

About VXRT Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Share on Social Networks: